↓ Skip to main content

Dove Medical Press

Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study

Overview of attention for article published in Neuropsychiatric Disease and Treatment, February 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter
2 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
91 Mendeley
Title
Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study
Published in
Neuropsychiatric Disease and Treatment, February 2013
DOI 10.2147/ndt.s41557
Pubmed ID
Authors

Michele Fornaro, Michael J McCarthy, Domenico De Berardis, Concetta De Pasquale, Massimo Tabaton, Matteo Martino, Salvatore Colicchio, Carlo Ignazio Cattaneo, Emanuela D’Angelo, Pantaleo Fornaro

Abstract

The circadian rhythm hypothesis of bipolar disorder (BD) suggests a role for melatonin in regulating mood, thus extending the interest toward the melatonergic antidepressant agomelatine as well as type I (acute) or II cases of bipolar depression.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Spain 1 1%
Italy 1 1%
Unknown 88 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 14%
Student > Postgraduate 10 11%
Researcher 9 10%
Student > Ph. D. Student 8 9%
Student > Doctoral Student 6 7%
Other 20 22%
Unknown 25 27%
Readers by discipline Count As %
Medicine and Dentistry 30 33%
Neuroscience 5 5%
Psychology 5 5%
Social Sciences 4 4%
Agricultural and Biological Sciences 3 3%
Other 13 14%
Unknown 31 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 February 2018.
All research outputs
#7,212,870
of 25,394,764 outputs
Outputs from Neuropsychiatric Disease and Treatment
#913
of 3,131 outputs
Outputs of similar age
#71,955
of 291,369 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#13
of 43 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 3,131 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 291,369 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.